Name (Synonyms) | Correlation | |
---|---|---|
drug331 | BBV152B Wiki | 1.00 |
drug330 | BBV152A Wiki | 1.00 |
drug332 | BBV152C Wiki | 1.00 |
drug2122 | Placebo Wiki | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.
Description: Evaluation of serum-prevalence data transplanted patients (symptomatic vs asymptomatic patients)
Measure: Serum-prevalence of COVID-19 TX Time: From 15 July 2020 to 15 January 2021Description: Correlation serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients
Measure: Serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients Time: From 15 July 2020 to 15 January 2021Description: Determine % Asymptomatic or subclinical infections in transplanted patients
Measure: Asymptomatic or subclinical infections in transplanted patients Time: From 15 July 2020 to 15 January 2021Description: Determine risk factors for infection COVID-19 (comparison symtomatic and asymtomatic transplanted patients)
Measure: Risk factors for infection COVID-19 transplanted patients Time: From 15 July 2020 to 15 January 2021Description: Evaluate hospitalization rate in transplanted patients
Measure: Hospitalization rate COVID-19 transplanted patients Time: From 15 July 2020 to 15 January 2021Description: Evaluate mortality rate in transplanted patients
Measure: Mortality rate COVID-19 transplanted patients Time: From 15 July 2020 to 15 January 2021